Oxford Index Search Results

You are looking at 1-10 of 10,164 items for:

gastrointestinal x clear all

Refine by subject

 

Refine by type

Refine by product

 

gastrointestinal

Overview page. Subjects: Medicine and Health.

(GI) (gas-troh-in-test-i-năl)

denoting, relating to, or affecting the stomach and intestines. g. stromal tumour (GIST) a tumour arising from the gastrointestinal tract that...

See overview in Oxford Index

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)

T. Ruers, C. Punt, F. Van Coevorden, J. P. E. N. Pierie, I. Borel-Rinkes, J. A. Ledermann, G. Poston, W. Bechstein, M. A. Lentz, M. Mauer, E. Van Cutsem, M. P. Lutz and B. Nordlinger.

in Annals of Oncology

October 2012; p ublished online March 2012 .

Journal Article. Subjects: Medical Oncology. 4504 words.

Background

This study investigates the possible benefits of radiofrequency ablation (RFA) in patients with non-resectable colorectal liver metastases.

null...

Go to Oxford Journals »  abstract

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study

E. Aranda, E. Díaz-Rubio, A. Cervantes, A. Antón-Torres, A. Carrato, T. Massutí, J. M. Tabernero, J. Sastre, A. Trés, J. Aparicio, J. M. López-Vega, I. Barneto and J. García-Conde.

in Annals of Oncology

July 1998; p ublished online July 1998 .

Journal Article. Subjects: Medical Oncology. 0 words.

Purpose

The objective of this multicenter study was to compare the efficacy and toxicity profiles of a combination of 5-fluorouracil (5-FU) given by bolus...

Go to Oxford Journals »  abstract

Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial

E. Aranda, A. Cervantes, A. Carrato, C. Fern´ndez-Martos, A. Antón-Torres, T. Massutí, I. Barneto, J. García-Conde, J. M Barón and E. Díaz-Rubio.

in Annals of Oncology

August 1996 .

Journal Article. Subjects: Medical Oncology. 0 words.

Background:

Background: In a previous phase I–II trial we showed that maximum tolerable dose (MTD) of 5-fluorouracil (5-FU) a weekly 48-hour continuous...

Go to Oxford Journals »  abstract

Susceptibility genetic variants associated with early-onset colorectal cancer

María Dolores Giráldez, Adriana López-Dóriga, Luis Bujanda, Anna Abulí, Xavier Bessa, Ceres Fernández-Rozadilla, Jenifer Muñoz, Miriam Cuatrecasas, Rodrigo Jover, Rosa M. Xicola, Xavier Llor, Josep M. Piqué, Angel Carracedo, Clara Ruiz-Ponte, Angel Cosme, José María Enríquez-Navascués, Victor Moreno, Montserrat Andreu, Antoni Castells, Francesc Balaguer and Sergi Castellví-Bel.

in Carcinogenesis

March 2012; p ublished online January 2012 .

Journal Article. Subjects: Clinical Cytogenetics and Molecular Genetics. 4370 words.

Colorectal cancer (CRC) is the second most common cancer in Western countries. Hereditary forms only correspond to 5% of CRC burden. Recently, genome-wide association studies have...

Go to Oxford Journals »  abstract

Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506

Hiroshi Ishii, Junji Furuse, Narikazu Boku, Takuji Okusaka, Masafumi Ikeda, Shinichi Ohkawa, Akira Fukutomi, Yasuo Hamamoto, Kenichi Nakamura and Haruhiko Fukuda.

in Japanese Journal of Clinical Oncology

June 2010; p ublished online February 2010 .

Journal Article. Subjects: Medical Oncology. 3745 words.

Objective

Chemoradiotherapy with 5-fluorouracil has been accepted as a standard care for locally advanced pancreatic cancer; however, it has not been shown...

Go to Oxford Journals »  abstract

A Phase I/II Trial of Radiotherapy Concurrent with TS-1 Plus Cisplatin in Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205

Motohiro Imano, Hiroshi Furukawa, Masaki Yokokawa, Yasumasa Nishimura, Yukinori Kurokawa, Taroh Satoh, Daisuke Sakai, Takushi Yasuda, Haruhiko Imamoto, Toshimasa Tujinaka, Toshio Shimokawa and Hitoshi Shiozaki.

in Japanese Journal of Clinical Oncology

April 2013; p ublished online February 2013 .

Journal Article. Subjects: Medical Oncology. 2357 words.

A Phase I/II trial of radiotherapy administered concurrently with TS-1 plus cisplatin has been initiated in Japanese patients with clinical resectable type 4 or large type 3 gastric cancer....

Go to Oxford Journals »  abstract

Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (JCOG0106)

Kuniaki Shirao, Narikazu Boku, Yasuhide Yamada, Kensei Yamaguchi, Toshihiko Doi, Masahiro Goto, Junichiro Nasu, Tadamichi Denda, Yasuo Hamamoto, Atsuo Takashima, Haruhiko Fukuda and Atsushi Ohtsu.

in Japanese Journal of Clinical Oncology

October 2013; p ublished online September 2013 .

Journal Article. Subjects: Medical Oncology. 4334 words.

Objective

Owing to the risks of serious and sustained toxicity, anticancer drugs such as cisplatin and irinotecan cannot be readily administered to patients...

Go to Oxford Journals »  abstract

Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial

Nicole Mittmann, Heather-Jane Au, Dongsheng Tu, Christopher J. O'Callaghan, Pierre K. Isogai, Christos S. Karapetis, John R. Zalcberg, William K. Evans, Malcolm J. Moore, Jehan Siddiqui, Brian Findlay, Bruce Colwell, John Simes, Peter Gibbs, Matthew Links, Niall C. Tebbutt and Derek J. Jonker.

in JNCI: Journal of the National Cancer Institute

September 2009; p ublished online September 2009 .

Journal Article. Subjects: Medical Oncology. 7218 words.

Background

The National Cancer Institute of Canada Clinical Trials Group CO.17 study showed that patients with advanced colorectal cancer had improved...

Go to Oxford Journals »  abstract

Interpretability of the PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in Pediatric Patients With Functional and Organic Gastrointestinal Diseases

James W. Varni, Cristiane B. Bendo, Robert J. Shulman, Mariella M. Self, Samuel Nurko, James P. Franciosi, Miguel Saps, Shehzad Saeed, George M. Zacur, Chelsea Vaughan Dark and John F. Pohl.

in Journal of Pediatric Psychology

July 2015; p ublished online February 2015 .

Journal Article. Subjects: Child and Adolescent Psychiatry; Psychology. 9518 words.

Objective The present study investigates the clinical interpretability of the Pediatric Quality of Life Inventory™ (PedsQL™) Gastrointestinal Symptoms Scales and Worry Scales...

Go to Oxford Journals »  home page

Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experience

Sergi Castellví-Bel, Clara Ruiz-Ponte, Ceres Fernández-Rozadilla, Anna Abulí, Jenifer Muñoz, Xavier Bessa, Alejandro Brea-Fernández, Marta Ferro, María Dolores Giráldez, Rosa M. Xicola, Xavier Llor, Rodrigo Jover, Josep M. Piqué, Montserrat Andreu, Antoni Castells and Angel Carracedo.

in Mutagenesis

March 2012; p ublished online March 2012 .

Journal Article. Subjects: Clinical Cytogenetics and Molecular Genetics; Genetics and Genomics. 4898 words.

The EPICOLON consortium was initiated in 1999 by the Gastrointestinal Oncology Group of the Spanish Gastroenterology Association. It recruited consecutive, unselected, population-based...

Go to Oxford Journals »  abstract